PDCD1LG2 and plasma cell myeloma: In addition to this, hematologic malignancies, such as multiple myeloma (MM), acute leukemia and chronic lymphocytic leukemia (CLL), have been shown to express PD-L1 or PD-L2 to some degree (7–13).